Events

Symeres actively participates in many international Life Sciences conferences. See below for some of the upcoming events where you can meet us and discuss your R&D services needs.

  • BIO 2024 International Convention 3-6 June, San Diego, USA

    Symeres is glad to announce that Bart DeCorte and Dimitri Pappaioannou (Oncolines) will be attending the BIO 2024 International Convention in San Diego! Would you like to engage in scientific discussions and learn more about Symeres’ extensive Drug Discovery and Development services? We encourage you to set up a meeting upfront via the partnering platform. Let’s connect and explore how we can collaborate! See you in San Diego!

    Bart DeCorte
    Dimitri Pappaioannou
  • Precision in Drug Discovery & Preclinical Summit 10-11 June, Boston, USA

    Symeres is excited to participate in the Precision in Drug Discovery & Preclinical Summit on June 10-11 in Boston. Our team will include Rory Curtis, Vice President of Business Development, and Leah Haydock, Director of Business Development. We are pleased to announce that Rory Curtis will be moderating a panel discussion titled “Is the Hype of AI Over for Drug Development?” on June 11th from 12:15 PM to 12:50 PM EST. This engaging panel will feature: Svetlana Marukian, Vice President, Research and Development at Evolved by Nature, Pat Walters, Chief Data Officer at Relay Therapeutics, Govinda Bhisetti, Vice President and Head of Computational Chemistry at Cellarity, Jeff Yang, CSO at Phil Rivers Technology. We are confident this hot topic will capture your interest! Join us at PDDP to connect with our team and explore this and other pressing topics in drug discovery and preclinical research.

    Leah Haydock
  • 6th RSC-BMCS / DMDG New Perspectives in DMPK 17 june, Liverpool, UK

    Join the Symeres team at the 6th RSC-BMCS/DMDG New Perspectives in DMPK in Liverpool! Sascha Hartmann, Director of Business Development, and Laszlo Szilagyi, Director of Business Development at Admescope (a Symeres company), will be delighted to discuss how we can support you. We have extensive experience in small molecules drug R&D, but also molecular glues, PROTACs, macrocycles, and many other modalities. Additionally, let’s explore our ADME-Tox profiling platform and in vivo DMPK services to support your pharmaceutical discovery and development programs. Stop by our booth number 3; we are eager to assist you!

    Sascha Hartmann
    Lazlo
  • Chemspec Europe 2024 19-20 June, Düsseldorf, Germany

    Symeres will be present at Chemspec Europe 2024, the 37th International Exhibition for Fine and Speciality Chemicals, June 19-20, 2024, in Hall 3 at Messe Düsseldorf in Germany. The team will consist of André de Vries, Director of Innovation and Business Development, and Kirill Kulish, Business Development Scientist. André will deliver a presentation on one of his favorite topics, “Green Chemistry in Drug Development and Manufacturing.” It’s important to produce drugs with as little harm to our planet as possible! If you’re curious about this topic or want to learn more about Symeres’ capabilities, please send André de Vries or Kirill Kulish a personal message. Make sure to reach out to our team and meet them at Chemspec!

    Kirill Kulish
    Andre de Vries
  • 38th ACS National Medicinal Chemistry Symposium 23-26 June, Seattle, USA

    Symeres is happy to announce that our Head of Business Development Russell Thomas and our VP Business Development Bart DeCorte will be representing Symeres at The 38th National Medicinal Chemistry Symposium in Seattle, WA, from June 23-26. Our team will be joined by Maria Pia Catalani, Director Lead Discovery at our long-term partner Axxam. You can visit us at booth number 10. Our seasoned team brings a wealth of knowledge and innovation, so join them to explore cutting-edge research, discuss the latest industry trends, and discover how Symeres is pushing the boundaries of drug discovery and development. Don’t miss this opportunity to connect with Russell, Bart, and Maria Pia, to network with fellow professionals, and gain insights into the future of medicinal chemistry. Please contact Bart via Bart.DeCorte@Symeres.com if you want to set up a meeting upfront. See you in Seattle!

    Russ Thomas
    Bart DeCorte
    Maria Pia Catalani
  • 58th International Conference on Medicinal Chemistry 3-5 July, Bordeaux, France

    Symeres is happy to announce its participation at the 58th International Conference on Medicinal Chemistry (RICT 2024), happening in Bordeaux, France, from July 3-5! Our team, consisting of Norimasa Morita, Director of Business Development; Ana Rioz, Business Development Scientist; and Luc Van Hijfte, Senior VP Drug Discovery at Symeres and EFMC President, will be attending. Join us at this inspiring event focused on bridging Chemical Biology and Drug Discovery. We are eager to learn more about RNA Binding Molecules, new modalities for Drug Discovery, recent trends in CNS disease drug development, and much more. Are you curious about Symeres’ expertise on these topics and want to engage in a discussion with us? Make sure to visit our booth, number 24! We look forward to seeing you there and exploring how we can collaborate!

    Luc van Hijfte
    Norimasa Morita
    Ana Rioz

Feel free to contact us!

Curious to know more about what can we do for you? Get in touch and let’s start a conversation.

Contact us